Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag updated from Revision: v3.5.3 to Revision: v3.5.4. This represents a minor version update to the entry's metadata.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Chicago Ridge site ZIP code was updated from 60451 to 60415. The site's recruitment status changed to Completed and Active, not recruiting, indicating enrollment activity at that location has shifted.SummaryDifference0.5%

- Check39 days agoChange DetectedThis update reflects a change in the ClinicalTrials.gov page’s revision/version indicator from v3.5.2 to v3.5.3, without altering the study’s substantive details.SummaryDifference0.0%

- Check47 days agoChange DetectedA new site, Advanced Urology Institute 1, was added and the previous Advanced Urology Institute was removed. The page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check54 days agoChange Detected- Removed the topic 'Bladder cancer' and the related topic 'MedlinePlus Genetics' from the page's topic list.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded related topic 'Bladder cancer' and MedlinePlus Genetics link. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.